🇦🇺 Visipaque 270 in Australia

Visipaque 270 (IODIXANOL) regulatory status in Australia.

Marketing authorisation

TGA

  • Status: likely_approved

Visipaque 270 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in Australia

Frequently asked questions

Is Visipaque 270 approved in Australia?

Yes. TGA has authorised it.

Who is the marketing authorisation holder for Visipaque 270 in Australia?

GE HealthCare is the originator. The local marketing authorisation holder may differ — check the official source linked above.